GTC Biotherapeutics (fka GTCB)

[Pre_Clinical]

<<<<
To whit.... Dr Meade stated at the shareholder meeting, the glycosylation patterns on the cellular mediated antibodies created by the goats enhanced the affinity of the natural killer cells to the attached antibodies and improved their clinical efficacy over that of cell culture derived variety.

I read that as well and find this tremendously promising. However, I would love to see the data. It certainly should be publishable in a top tier, peer-reviewed journal, perhaps Nature Biotechnology.